Showing results (161-170 of 2,325) with videos related to
Sort By:
Pageof 233
Journal of Cardiovascular Pharmacology|February 15, 2000
Treatment of atherosclerosis in apolipoprotein E-deficient mice with 4-(3-Bromobenzoyl)-6,7-dimethoxyquinazoline (WHI-P164), a potent inhibitor of triglyceride synthesisV N Trieu, X P Liu, C L Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
A requirement for protein kinase C inhibition for calcium-triggered apoptosis in acute lymphoblastic leukemia cellsD M Zhu, W H Fang, R K Narla, et al.Journal of Immunological Methods|July 6, 1989
The effects of aromatic and aliphatic maleimide crosslinkers on anti-CD5 ricin immunotoxinsD E Myers, F M Uckun, S E Swaim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
4-(3'-Bromo-4'hydroxylphenyl)-amino-6,7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cellsR K Narla, X P Liu, D E Myers, et al.Blood|February 15, 1992
Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purgingF M Uckun, J H Kersey, R Haake, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|June 9, 1999
Quantitative high-performance liquid chromatographic method for pharmacokinetic studies of the potent mast cell inhibitor 4-(4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P131)C L Chen, R Malaviya, H Chen, et al.Current Pharmaceutical Design|June 8, 2004
Rational drug design of multifunctional phosphoramidate substituted nucleoside analogsT K Venkatachalam, P A Goodman, S Qazi, et al.The Journal of Biological Chemistry|June 20, 2001
Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cellsS Mahajan, A Vassilev, N Sun, et al.Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Structure-based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptaseC Mao, R Vig, T K Venkatachalam, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agentR K Narla, Y Dong, O J D'Cruz, et al.Pageof 233